Wei-Chang Lee
Papers
1
Total Citations
5
H-Index
1
About
Dr. Wei-Chang Lee is a urologic oncologist whose research focuses on optimizing treatment strategies for high-risk prostate cancer. His most cited work investigates the role of neoadjuvant hormone therapy (NHT) prior to robotic-assisted radical prostatectomy, demonstrating that this approach can achieve favorable outcomes in patients with aggressive disease. By addressing the challenge of positive surgical margins and biochemical recurrence, Dr. Lee’s contributions help refine multimodal management for high-risk prostate carcinoma. Though his top-cited paper has accumulated 5 citations, its clinical significance lies in offering evidence for combining NHT with minimally invasive surgery to improve patient prognosis. Dr. Lee’s research bridges surgical innovation and oncologic efficacy, providing valuable insights for urologists and oncologists seeking to enhance survival and quality of life in this challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1